NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$50.56 +0.38 (+0.76 %)
(As of 04/26/2019 12:07 PM ET)
Previous Close$50.18
Today's Range$50.06 - $50.62
52-Week Range$33.93 - $51.50
Volume20,585 shs
Average Volume1.82 million shs
Market Capitalization$11.31 billion
P/E Ratio25.15
Dividend Yield0.69%
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:XRAY



Sales & Book Value

Annual Sales$3.99 billion
Cash Flow$8.5550 per share
Book Value$23.07 per share


Net Income$-1,011,000,000.00


Market Cap$11.31 billion
Next Earnings Date5/3/2019 (Confirmed)

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Wednesday, February 27th. Investors of record on Friday, March 29th will be given a dividend of $0.087 per share on Friday, April 12th. This represents a $0.35 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Thursday, March 28th. View DENTSPLY SIRONA's Dividend History.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) posted its quarterly earnings data on Friday, March, 1st. The medical instruments supplier reported $0.58 earnings per share for the quarter, beating analysts' consensus estimates of $0.54 by $0.04. The medical instruments supplier earned $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The firm's quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the company earned $0.82 EPS. View DENTSPLY SIRONA's Earnings History.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Friday, May 3rd 2019. View Earnings Estimates for DENTSPLY SIRONA.

How can I listen to DENTSPLY SIRONA's earnings call?

DENTSPLY SIRONA will be holding an earnings conference call on Friday, May 3rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8773707637.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA updated its FY19 earnings guidance on Friday, March, 1st. The company provided earnings per share guidance of $2.25-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.18. DENTSPLY SIRONA also updated its FY 2019 guidance to $2.25-2.40 EPS.

What price target have analysts set for XRAY?

15 equities research analysts have issued 1 year price targets for DENTSPLY SIRONA's stock. Their predictions range from $40.00 to $75.00. On average, they anticipate DENTSPLY SIRONA's stock price to reach $52.0507 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price. View Analyst Price Targets for DENTSPLY SIRONA.

What is the consensus analysts' recommendation for DENTSPLY SIRONA?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for DENTSPLY SIRONA.

What are Wall Street analysts saying about DENTSPLY SIRONA stock?

Here are some recent quotes from research analysts about DENTSPLY SIRONA stock:
  • 1. According to Zacks Investment Research, "DENTSPLY continues to gain from its CAD/CAM profile. The company also announced its restructuring plan, which is expected to boost top line. In the coming quarters, DENTSPLY expects to see strong revenue growth in Europe. Management also foresees high-single digit growth opportunities in Latin America and China. On the flip side, the company’s earnings and revenues also declined on a year-over-year basis in the last reported quarter. Moreover, core Technology & Equipment growth was marred by factors like inventory destocking and disruption from its distribution infrastructure in Venlo. Significant contractions in gross and operating margins also add to the woes. DENTSPLY underperformed the industry over the past year. " (3/9/2019)
  • 2. Barrington Research analysts commented, "We suspect modest progress can be made in 2019, but this plan will take two to three years, at least, to impact in a material way – even in management’s view." (11/9/2018)
  • 3. HC Wainwright analysts commented, "Our price target is derived from a comparable universe-based approach, which utilizes a price-to-earnings (P/E) multiple calculated from a group of peer companies in the medical and dental equipment arenas." (8/31/2018)

Has DENTSPLY SIRONA been receiving favorable news coverage?

Media coverage about XRAY stock has trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the near future.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a decline in short interest in March. As of March 15th, there was short interest totalling 7,380,199 shares, a decline of 15.5% from the February 28th total of 8,735,685 shares. Based on an average daily volume of 2,526,607 shares, the short-interest ratio is currently 2.9 days. Approximately 3.4% of the shares of the company are sold short. View DENTSPLY SIRONA's Current Options Chain.

Who are some of DENTSPLY SIRONA's key competitors?

Some companies that are related to DENTSPLY SIRONA include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), BIOLASE (BIOL), Biomerica (BMRA) and Remedent (REMI).

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include Micron Technology (MU), General Electric (GE), NVIDIA (NVDA), Intel (INTC), Gilead Sciences (GILD), QUALCOMM (QCOM), Starbucks (SBUX), Celgene (CELG), Cisco Systems (CSCO) and Microchip Technology (MCHP).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the folowing people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 59)
  • Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different of retail and institutional investors. Top institutional investors include DNB Asset Management AS (0.92%), Douglas Lane & Associates LLC (0.65%), BTIM Corp. (0.21%), Kirr Marbach & Co. LLC IN (0.08%), Clean Yield Group (0.05%) and Los Angeles Capital Management & Equity Research Inc. (0.05%). Company insiders that own DENTSPLY SIRONA stock include Donald M Jr Casey, Eric Brandt, Francis J Lunger, Mark Thierer, Markus Boehringer, Michael C Alfano, Michael J Coleman and Nicholas W Alexos. View Institutional Ownership Trends for DENTSPLY SIRONA.

Which major investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Mycio Wealth Partners LLC, Hills Bank & Trust Co., Bath Savings Trust Co, LS Investment Advisors LLC, State of Alaska Department of Revenue, LaFleur & Godfrey LLC, Fulton Bank N.A. and Gateway Investment Advisers LLC. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Markus Boehringer, Michael C Alfano and Michael J Coleman. View Insider Buying and Selling for DENTSPLY SIRONA.

Which major investors are buying DENTSPLY SIRONA stock?

XRAY stock was bought by a variety of institutional investors in the last quarter, including Kirr Marbach & Co. LLC IN, DNB Asset Management AS, W.E. Donoghue & Co. LLC, Los Angeles Capital Management & Equity Research Inc., Tributary Capital Management LLC, BTIM Corp., Meeder Asset Management Inc. and Nisa Investment Advisors LLC. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $50.56.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $11.31 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,011,000,000.00 in net income (profit) each year or $2.01 on an earnings per share basis. DENTSPLY SIRONA employs 16,400 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]

MarketBeat Community Rating for DENTSPLY SIRONA (NASDAQ XRAY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  335 (Vote Outperform)
Underperform Votes:  354 (Vote Underperform)
Total Votes:  689
MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/26/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel